Abstract: A refuse vehicle includes a chassis, an energy storage device supported by the chassis and configured to provide electrical power to a prime mover, wherein activation of the prime mover selectively drives the refuse vehicle, a body for storing refuse therein supported by the chassis, a first hydraulic pump configured to convert electrical power into hydraulic power, a second first hydraulic pump configured to convert electrical power into hydraulic power, and a motor coupled to at least one of the body or the chassis and configured to drive the first hydraulic pump and drive the second hydraulic pump.

Abstract: The invention relates to a cartridge for an analysis method which is rotation-based and utilizes one-sided heat input. The cartridge has a planar main body in which a microfluidic channel-and-chamber structure is formed, with channels interconnecting multiple process chambers, a number of positioning and/or fastening elements, formed in the main body, for positioning and/or fastening the main body on/to a support plate of an analyzer for carrying out the analysis method, and a cover body which is fastened to the main body and which is one-sidedly arranged on a top side of the main body that faces away from a heat input side and which covers at least a chamber.

Abstract: The claimed method relates to a method for reducing blood loss. More specifically, the claimed method utilizes at least one compound deposited within and/or on a medical applicator to reduce blood loss experienced by a user. In some embodiments, the method may include depositing at least one compound onto or within a medical applicator which promotes diminished blood flow and coagulation when the applicator is used. More specifically, the medical applicator may have a compound adhered to the surface which acts as a catalyst to instigate blood clotting when the medical applicator is used for its intended purpose. In some embodiments, an antifibrinolytic may be deposited onto the medical applicator. In other embodiments, compounds causing vasoconstriction may be deposited onto the medical applicator. In yet other embodiments, a plurality of compounds may be deposited within and/or on the surface of the medical applicator.